Cergentis
Cergentis provides services and kits based on its proprietary 'Targeted Locus Amplification' (TLA) technology.
Operating in biotechnology, genetics, medical based in European Union (EU), Europe, Middle East, and Africa (EMEA), Cergentis was founded in 2012.
As a business in biotechnology, genetics, medical, Cergentis is listed here with the public details available about it.
European Union (EU), Europe, Middle East, and Africa (EMEA) is where the company is located.
The company is listed at the Grant stage of development.
The company reports a headcount in the c_00011_00050 range.
Total disclosed funding stands at about $1.9M.
| Sector | Biotechnology, Genetics, Medical |
|---|---|
| Headquarters | European Union (EU), Europe, Middle East, and Africa (EMEA) |
| Founded | 2012 |
| Employees | c_00011_00050 |
| Stage | grant |
| Total funding | $1,851,000 |
Website: www.cergentis.com
Full contact details are available to registered Pixilab members.
Create a free account
Create a free account